These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Author: Bhattacharya MK, Nair GB, Sen D, Paul M, Debnath A, Nag A, Dutta D, Dutta P, Pal SC, Bhattacharya SK.
    Journal: J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968.
    Abstract:
    In a double-blind, randomised, clinical trial on 122 adults with acute Shigella dysentery, 60 patients were treated with norfloxacin and 62 with nalidixic acid. Of these, 32 patients in the norfloxacin group and 28 patients in the nalidixic acid group had Shigella in their stool. Patients of the two treatment groups were clinically comparable on admission. No significant differences in clinical responses were observed in the two groups among the Shigella-positive cases, Shigella-negative cases and among the total cases. All isolates of Shigella were susceptible to norfloxacin, whereas 13.8% of the strains were resistant to nalidixic acid.
    [Abstract] [Full Text] [Related] [New Search]